Paper16372012
NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury.
Salter MG and 1 other. Nature, 2005. Cited by 435 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury. Papers, record 16372012. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16372012
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ischemia | Major topic |
| Oligodendroglia | Major topic |
| Receptors, N-Methyl-D-Aspartate | Major topic |
| Animals | |
| Calcium | |
| Female | |
| Male | |
| Mice | |
| Mice, Transgenic | |
| Optic Nerve | |
| RNA, Messenger | |
| Receptors, AMPA | |
| Kainic Acid Receptors |
Source PubMed
Cited by263
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 435 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,985,291 | Integrating multi-receptor and neuron-glia mechanisms of ketamine's antidepressant action: a convergence framework for understanding efficacy. | Front Mol Neurosci | 2026 | https://conductscience.org/library/papers/42985291 | PubMed |
| 41,978,136 | The Flavonoid Apigenin Modulates Oligodendroglial Plasticity and Has a Neuroprotective Effect in Cerebellar Slice Cultures with Oxygen Glucose Deprivation. | Nutrients | 2026 | https://conductscience.org/library/papers/41978136 | PubMed |
| 41,918,880 | Glial D-serine modulates oligodendrocyte lineage progression under inflammatory conditions. | Front Cell Neurosci | 2026 | https://conductscience.org/library/papers/41918880 | PubMed |
| 41,839,574 | Endothelial NMDA Receptor Involvement in Retinal Neurovascular Damage Following Prenatal Alcohol Exposure in a Mouse Model. | J Neurosci | 2026 | https://conductscience.org/library/papers/41839574 | PubMed |
| 41,713,186 | A subunit-selective negative allosteric modulator of GluN1/GluN3A glycine-activated receptor. | Mol Pharmacol | 2026 | https://conductscience.org/library/papers/41713186 | PubMed |
| 41,601,534 | Potential molecular pathways and therapeutic implications of rapid-acting antidepressants on myelin biology: a scoping review. | Front Neurosci | 2025 | https://conductscience.org/library/papers/41601534 | PubMed |
| 41,019,422 | The interaction between resilience framework and neuron-astrocyte-synapse dynamics in AD. | Front Aging Neurosci | 2025 | https://conductscience.org/library/papers/41019422 | PubMed |
| 40,887,454 | Brain Magnetic Resonance Imaging of Children With Molybdenum Cofactor Deficiency. | J Inherit Metab Dis | 2025 | https://conductscience.org/library/papers/40887454 | PubMed |
| 40,806,469 | Roles of Ion Channels in Oligodendrocyte Precursor Cells: From Physiology to Pathology. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40806469 | PubMed |
| 40,791,909 | Serum homocysteine levels predict poor recovery and relapse in first-attack myelin oligodendrocyte glycoprotein antibody disease. | Front Neurol | 2025 | https://conductscience.org/library/papers/40791909 | PubMed |
| 40,500,497 | Physiology of Oligodendroglia. | Adv Neurobiol | 2025 | https://conductscience.org/library/papers/40500497 | PubMed |
| 40,358,653 | Revisiting the critical roles of reactive microglia in traumatic brain injury. | Int J Surg | 2025 | https://conductscience.org/library/papers/40358653 | PubMed |
| 40,235,311 | The GluN3-containing NMDA receptors. | Channels (Austin) | 2025 | https://conductscience.org/library/papers/40235311 | PubMed |
| 39,275,007 | Neuroprotective Effect of Flavonoid Agathisflavone in the Ex Vivo Cerebellar Slice Neonatal Ischemia. | Molecules | 2024 | https://conductscience.org/library/papers/39275007 | PubMed |
| 39,230,890 | Axonal neurotransmitter release in the regulation of myelination. | Biosci Rep | 2024 | https://conductscience.org/library/papers/39230890 | PubMed |
| 38,963,434 | Cerebral White Matter Alterations Associated With Oligodendrocyte Vulnerability in Organic Acidurias: Insights in Glutaric Aciduria Type I. | Neurotox Res | 2024 | https://conductscience.org/library/papers/38963434 | PubMed |
| 38,029,392 | The Emerging Role of Microglial Hv1 as a Target for Immunomodulation in Myelin Repair. | Aging Dis | 2024 | https://conductscience.org/library/papers/38029392 | PubMed |
| 38,026,691 | Activity-dependent oligodendrocyte calcium dynamics and their changes in Alzheimer's disease. | Front Cell Neurosci | 2023 | https://conductscience.org/library/papers/38026691 | PubMed |
| 37,985,182 | What Are the Roles of Oligodendrocyte Precursor Cells in Normal and Pathologic Conditions? | Neurology | 2023 | https://conductscience.org/library/papers/37985182 | PubMed |
| 37,686,003 | Pluripotential GluN1 (NMDA NR1): Functional Significance in Cellular Nuclei in Pain/Nociception. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37686003 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16372012
GET https://conductscience.org/api/papers/v1/16372012/cited_by?page=2